Logo image
p53 Hinders CRISPR/Cas9-Mediated Targeted Gene Disruption in Memory CD8 T Cells In Vivo
Journal article   Peer reviewed

p53 Hinders CRISPR/Cas9-Mediated Targeted Gene Disruption in Memory CD8 T Cells In Vivo

Samarchith P Kurup, Steven J Moioffer, Lecia L Pewe and John T Harty
The Journal of immunology (1950), Vol.205(8), pp.2222-2230
10/15/2020
DOI: 10.4049/jimmunol.2000654
PMCID: PMC7541733
PMID: 32887747
url
https://www.ncbi.nlm.nih.gov/pmc/articles/7541733View
Open Access

Abstract

CRISPR/Cas9 technology has revolutionized rapid and reliable gene editing in cells. Although many cell types have been subjected to CRISPR/Cas9-mediated gene editing, there is no evidence of success in genetic alteration of Ag-experienced memory CD8 T cells. In this study, we show that CRISPR/Cas9-mediated gene editing in memory CD8 T cells precludes their proliferation after Ag re-encounter in vivo. This defect is mediated by the proapoptotic transcription factor p53, a sensor of DNA damage. Temporarily inhibiting p53 function offers a window of opportunity for the memory CD8 T cells to repair the DNA damage, facilitating robust recall responses on Ag re-encounter. We demonstrate this by functionally altering memory CD8 T cells using CRISPR/Cas9-mediated targeted gene disruption under the aegis of p53siRNA in the mouse model. Our approach thus adapts the CRISPR/Cas9 technology for memory CD8 T cells to undertake gene editing in vivo, for the first time, to our knowledge.
Animals Antigens - immunology CD8-Positive T-Lymphocytes - immunology Cell Proliferation - genetics CRISPR-Cas Systems DNA Damage - genetics DNA Damage - immunology Immunologic Memory - genetics Mice Mice, Transgenic Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - immunology

Details

Metrics

Logo image